Managing Cancer Metabolically Part 2: Dr. Thomas Seyfried and Dr. Donese Worden

Dr. Thomas Seyfried YouTube Channel

In Part 2 of this in-depth metabolic oncology discussion, physician and researcher Dr. Donese Worden joins Professor Thomas Seyfried to answer important questions about metabolic cancer therapy, patient empowerment, and the future of metabolic oncology research.

This conversation expands on the scientific and clinical principles discussed in Part 1, exploring how metabolic strategies may work alongside conventional oncology approaches while helping patients better understand the complexities of cancer management.

Related: Watch Part 1 of the metabolic oncology conversation with Dr. Thomas Seyfried and Dr. Donese Worden.

Managing Cancer Metabolically

Dr. Worden and Professor Seyfried discuss the difference between managing cancer and promising unrealistic outcomes. They emphasize the importance of individualized care, informed decision-making, and avoiding practitioners who oversimplify complex diseases or overpromise results.

Working Alongside Traditional Oncology

The discussion also explores how metabolic oncology clinicians collaborate with conventional oncologists and how ketogenic metabolic therapy may sometimes be integrated alongside standard treatments.

Topics include patient monitoring, individualized metabolic approaches, and how supportive metabolic strategies may help patients tolerate treatment differently in certain situations.

The Metabolic Theory of Cancer

Professor Seyfried and Dr. Worden revisit the growing scientific discussion around cancer metabolism and mitochondrial function. They discuss why the metabolic theory of cancer continues to challenge long-standing assumptions about cancer biology and why institutional resistance to new paradigms often occurs in medicine.

Adjunctive and Supportive Therapies

The interview also explores adjunctive strategies frequently discussed in metabolic oncology, including ketogenic metabolic therapy and hyperbaric oxygen therapy. Dr. Worden emphasizes the importance of supporting healthy cells while targeting metabolic vulnerabilities associated with cancer cells.

The Importance of Patient Empowerment

A major theme throughout the discussion is patient empowerment. Dr. Worden explains why patients should stay actively involved in their healthcare decisions, ask questions, and seek clinicians who are transparent about both the possibilities and limitations of treatment strategies.

In This Interview You'll Learn

• How to avoid practitioners who oversimplify or overpromise cancer outcomes
• The difference between cancer management and claims of a “cure”
• How metabolic oncology clinicians collaborate with traditional oncologists
• Why the metabolic theory of cancer continues to gain scientific attention
• The role of ketogenic metabolic therapy and hyperbaric oxygen therapy
• Why patient education and empowerment are essential in complex disease management

Watch the full interview above to hear Dr. Donese Worden and Professor Thomas Seyfried discuss the evolving science and clinical application of metabolic oncology.